Reckitt Benckiser Group (LON:RKT - Get Free Report) had its target price dropped by research analysts at Berenberg Bank from GBX 5,200 ($67.51) to GBX 5,177 ($67.22) in a note issued to investors on Wednesday, MarketBeat Ratings reports. The brokerage currently has a "hold" rating on the stock. Berenberg Bank's price objective would indicate a potential upside of 6.50% from the stock's current price.
A number of other equities research analysts also recently issued reports on the stock. JPMorgan Chase & Co. downgraded shares of Reckitt Benckiser Group to a "neutral" rating in a research report on Friday, August 30th. Jefferies Financial Group reaffirmed a "hold" rating and issued a GBX 4,400 ($57.13) target price on shares of Reckitt Benckiser Group in a report on Monday, July 29th.
Check Out Our Latest Stock Report on Reckitt Benckiser Group
Reckitt Benckiser Group Stock Down 1.9 %
Shares of Reckitt Benckiser Group stock traded down GBX 92 ($1.19) on Wednesday, hitting GBX 4,861 ($63.11). The company had a trading volume of 2,134,034 shares, compared to its average volume of 3,350,471. The stock has a market capitalization of £33.60 billion, a price-to-earnings ratio of 2,261.29, a P/E/G ratio of 1.10 and a beta of 0.09. The company has a debt-to-equity ratio of 112.52, a quick ratio of 0.46 and a current ratio of 0.69. Reckitt Benckiser Group has a 1 year low of GBX 4,034 ($52.38) and a 1 year high of GBX 5,950 ($77.25). The stock has a 50 day moving average of GBX 4,532.62 and a 200-day moving average of GBX 4,420.32.
Insider Buying and Selling
In related news, insider Fiona Dawson bought 25 shares of the company's stock in a transaction on Wednesday, October 23rd. The shares were purchased at an average cost of GBX 4,923 ($63.92) per share, for a total transaction of £1,230.75 ($1,597.96). 0.05% of the stock is currently owned by corporate insiders.
About Reckitt Benckiser Group
(
Get Free Report)
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Recommended Stories
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
